Question follow-through · 59379

Coronavirus: Research

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 June 2025 to Question 53036 on Coronavirus: Research, when he plans to publish the audit; whether he plans to publish his Department's initial assessment of the PMCPA’s

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
12 Jun 2025
Target answer date
16 Jun 2025
Answer
23 Jun 2025 · 11 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 12 Jun 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 June 2025 to Question 53036 on Coronavirus: Research, when he plans to publish the audit; whether he plans to publish his Department's initial assessment of the PMCPA’s

  2. 16 Jun 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 23 Jun 2025

    Answer published

    The Prescription Medicines Code of Practice Authority (PMCPA) is a non-governmental, self-regulatory body, which independently administers the Association of the British Pharmaceutical Industry Code of Practice for the Pharmaceutical Industry.The UK Healt...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Antimicrobials: Small Businesses

16 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of new antimicrobial therapeutics developed by SMEs.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Antidepressants

16 Jun 2025 · To ask the Secretary of State for Health and Social Care, when he plans to publish the (a) minutes and (b) outcome of the Commission on Human Medicines Antidepressant Risk Minimisation Expert Working Group meeting which took place on 1 May.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Antidepressants

16 Jun 2025 · To ask the Secretary of State for Health and Social Care, if he will publish the dates of the consultation period with pharmaceutical companies, as agreed at the Commission on Human Medicines Antidepressant Risk Minimisation Expert Working Group meeting o

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Selective Serotonin Reuptake Inhibitors: Packaging

27 Jun 2025 · To ask the Secretary of State for Health and Social Care, when he plans to publish the report on packaging changes to Selective serotonin reuptake inhibitors, as discussed at the Commission on Human Medicines Antidepressant Risk Minimisation Expert Workin

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Patient Safety Commissioner

10 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to page 94 of his Department's policy paper entitled Fit for the future: 10 year health plan for England, published in July 2025, what assessment he has made of the potential impact

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Zoe Marketing & Communications

16 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to the FOI request 2024/00205, when the Medicines and Healthcare products Regulatory Agency plans to publish (a) details of its investigation into the advertising activities of the c

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Primodos: Civil Proceedings

17 Jul 2025 · To ask the Secretary of State for Health and Social Care, what litigation costs his Department incurred in Wilson and others v Bayer Pharma and others, [2023] EWHC 1282 (QB); and how many representatives of his Department attended the Royal Courts of Just

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Chiropractic

29 Aug 2025 · To ask the Secretary of State for Health and Social Care, if his Department will (a) support further integration of chiropractic care into NHS services across Tatton and (b) give chiropractors Allied Healthcare Professional status.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Chiropractic

29 Aug 2025 · To ask the Secretary of State for Health and Social Care, if his Department will consider reviewing the Allied Healthcare Professional status list to include chiropractors as part of the government’s wider review of the NHS.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Vaccine Damage Payment Scheme: Appeals

3 Sept 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 March 2025 to Question 34608 on Vaccine Damage Payment Scheme: Appeals, whether past tribunal decisions are used to support assessments.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Coronavirus: Vaccination

10 Sept 2025 · To ask the Secretary of State for Health and Social Care, how much funding his department allocated to the indemnity schemes in place for Covid-19 vaccinations.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Mental Health Services: Children

10 Oct 2025 · To ask the Secretary of State for Health and Social Care, with reference to FOI request 24/015 to the Medicines and Healthcare products Regulatory Agency, if he will publish the responses received from the Swedish Medical Products Agency following their o